http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 04 Mar 2026 09:16:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Azenta%2C+Inc.++++++++++++++For%3A+Mar+04/26108249.html si-local-file:///var/storage/secattach/20260304/26108249.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Azenta%2C+Inc.++++++++++++++For%3A+Mar+04/26108249.html Wed, 04 Mar 2026 09:16:00 -0500 AZTA O.00162109 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Azenta%2C+Inc.++++++++++++++For%3A+Mar+04/26108249.html si-local-file:///var/storage/secattach/20260304/26108249.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Azenta%2C+Inc.++++++++++++++For%3A+Mar+04/26108249.html Wed, 04 Mar 2026 09:16:00 -0500 AZTA O.00162109 http://www.streetinsider.com/Mergers+and+Acquisitions/Azenta+acquires+UK+Biocentre+Limited+for+GBP+20.5+million/26108207.html <p>Azenta, Inc. (NASDAQ: AZTA) announced that its subsidiary Azenta UK Ltd has acquired UK Biocentre Limited for GBP 20.5 million, net of cash and inclusive of up to GBP 1.8 million in contingent consideration upon completion of certain milestones.</p> <p>The acquisition expands Azenta's biorepository capabilities in the United Kingdom and establishes UK Biocentre as a European operational hub to support pharmaceutical, biotechnology, academic, and public health customers across the region. UK Biocentre will continue operating under its existing name and will support Azenta's established biorepository in Griesheim, Germany.</p> <p>Founded in 2014, UK Biocentre provides sample management, sample storage and high-throughput sample processing http://www.streetinsider.com/Mergers+and+Acquisitions/Azenta+acquires+UK+Biocentre+Limited+for+GBP+20.5+million/26108207.html Wed, 04 Mar 2026 09:11:17 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/Mergers+and+Acquisitions/Azenta+acquires+UK+Biocentre+Limited+for+GBP+20.5+million/26108207.html <p>Azenta, Inc. (NASDAQ: AZTA) announced that its subsidiary Azenta UK Ltd has acquired UK Biocentre Limited for GBP 20.5 million, net of cash and inclusive of up to GBP 1.8 million in contingent consideration upon completion of certain milestones.</p> <p>The acquisition expands Azenta's biorepository capabilities in the United Kingdom and establishes UK Biocentre as a European operational hub to support pharmaceutical, biotechnology, academic, and public health customers across the region. UK Biocentre will continue operating under its existing name and will support Azenta's established biorepository in Griesheim, Germany.</p> <p>Founded in 2014, UK Biocentre provides sample management, sample storage and high-throughput sample processing http://www.streetinsider.com/Mergers+and+Acquisitions/Azenta+acquires+UK+Biocentre+Limited+for+GBP+20.5+million/26108207.html Wed, 04 Mar 2026 09:11:17 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/Mergers+and+Acquisitions/Azenta+acquires+UK+Biocentre+Limited+for+GBP+20.5+million/26108207.html <p>Azenta, Inc. (NASDAQ: AZTA) announced that its subsidiary Azenta UK Ltd has acquired UK Biocentre Limited for GBP 20.5 million, net of cash and inclusive of up to GBP 1.8 million in contingent consideration upon completion of certain milestones.</p> <p>The acquisition expands Azenta's biorepository capabilities in the United Kingdom and establishes UK Biocentre as a European operational hub to support pharmaceutical, biotechnology, academic, and public health customers across the region. UK Biocentre will continue operating under its existing name and will support Azenta's established biorepository in Griesheim, Germany.</p> <p>Founded in 2014, UK Biocentre provides sample management, sample storage and high-throughput sample processing http://www.streetinsider.com/Mergers+and+Acquisitions/Azenta+acquires+UK+Biocentre+Limited+for+GBP+20.5+million/26108207.html Wed, 04 Mar 2026 09:11:17 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/Mergers+and+Acquisitions/Azenta+acquires+UK+Biocentre+Limited+for+GBP+20.5+million/26108207.html <p>Azenta, Inc. (NASDAQ: AZTA) announced that its subsidiary Azenta UK Ltd has acquired UK Biocentre Limited for GBP 20.5 million, net of cash and inclusive of up to GBP 1.8 million in contingent consideration upon completion of certain milestones.</p> <p>The acquisition expands Azenta's biorepository capabilities in the United Kingdom and establishes UK Biocentre as a European operational hub to support pharmaceutical, biotechnology, academic, and public health customers across the region. UK Biocentre will continue operating under its existing name and will support Azenta's established biorepository in Griesheim, Germany.</p> <p>Founded in 2014, UK Biocentre provides sample management, sample storage and high-throughput sample processing http://www.streetinsider.com/Mergers+and+Acquisitions/Azenta+acquires+UK+Biocentre+Limited+for+GBP+20.5+million/26108207.html Wed, 04 Mar 2026 09:11:17 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/Mergers+and+Acquisitions/Azenta+acquires+UK+Biocentre+Limited+for+GBP+20.5+million/26108207.html <p>Azenta, Inc. (NASDAQ: AZTA) announced that its subsidiary Azenta UK Ltd has acquired UK Biocentre Limited for GBP 20.5 million, net of cash and inclusive of up to GBP 1.8 million in contingent consideration upon completion of certain milestones.</p> <p>The acquisition expands Azenta's biorepository capabilities in the United Kingdom and establishes UK Biocentre as a European operational hub to support pharmaceutical, biotechnology, academic, and public health customers across the region. UK Biocentre will continue operating under its existing name and will support Azenta's established biorepository in Griesheim, Germany.</p> <p>Founded in 2014, UK Biocentre provides sample management, sample storage and high-throughput sample processing http://www.streetinsider.com/Mergers+and+Acquisitions/Azenta+acquires+UK+Biocentre+Limited+for+GBP+20.5+million/26108207.html Wed, 04 Mar 2026 09:11:17 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/Mergers+and+Acquisitions/Azenta+acquires+UK+Biocentre+Limited+for+GBP+20.5+million/26108207.html <p>Azenta, Inc. (NASDAQ: AZTA) announced that its subsidiary Azenta UK Ltd has acquired UK Biocentre Limited for GBP 20.5 million, net of cash and inclusive of up to GBP 1.8 million in contingent consideration upon completion of certain milestones.</p> <p>The acquisition expands Azenta's biorepository capabilities in the United Kingdom and establishes UK Biocentre as a European operational hub to support pharmaceutical, biotechnology, academic, and public health customers across the region. UK Biocentre will continue operating under its existing name and will support Azenta's established biorepository in Griesheim, Germany.</p> <p>Founded in 2014, UK Biocentre provides sample management, sample storage and high-throughput sample processing http://www.streetinsider.com/Mergers+and+Acquisitions/Azenta+acquires+UK+Biocentre+Limited+for+GBP+20.5+million/26108207.html Wed, 04 Mar 2026 09:11:17 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/Mergers+and+Acquisitions/Azenta+acquires+UK+Biocentre+Limited+for+GBP+20.5+million/26108207.html <p>Azenta, Inc. (NASDAQ: AZTA) announced that its subsidiary Azenta UK Ltd has acquired UK Biocentre Limited for GBP 20.5 million, net of cash and inclusive of up to GBP 1.8 million in contingent consideration upon completion of certain milestones.</p> <p>The acquisition expands Azenta's biorepository capabilities in the United Kingdom and establishes UK Biocentre as a European operational hub to support pharmaceutical, biotechnology, academic, and public health customers across the region. UK Biocentre will continue operating under its existing name and will support Azenta's established biorepository in Griesheim, Germany.</p> <p>Founded in 2014, UK Biocentre provides sample management, sample storage and high-throughput sample processing http://www.streetinsider.com/Mergers+and+Acquisitions/Azenta+acquires+UK+Biocentre+Limited+for+GBP+20.5+million/26108207.html Wed, 04 Mar 2026 09:11:17 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/Mergers+and+Acquisitions/Azenta+acquires+UK+Biocentre+Limited+for+GBP+20.5+million/26108207.html <p>Azenta, Inc. (NASDAQ: AZTA) announced that its subsidiary Azenta UK Ltd has acquired UK Biocentre Limited for GBP 20.5 million, net of cash and inclusive of up to GBP 1.8 million in contingent consideration upon completion of certain milestones.</p> <p>The acquisition expands Azenta's biorepository capabilities in the United Kingdom and establishes UK Biocentre as a European operational hub to support pharmaceutical, biotechnology, academic, and public health customers across the region. UK Biocentre will continue operating under its existing name and will support Azenta's established biorepository in Griesheim, Germany.</p> <p>Founded in 2014, UK Biocentre provides sample management, sample storage and high-throughput sample processing http://www.streetinsider.com/Mergers+and+Acquisitions/Azenta+acquires+UK+Biocentre+Limited+for+GBP+20.5+million/26108207.html Wed, 04 Mar 2026 09:11:17 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/Mergers+and+Acquisitions/Azenta+acquires+UK+Biocentre+Limited+for+GBP+20.5+million/26108207.html <p>Azenta, Inc. (NASDAQ: AZTA) announced that its subsidiary Azenta UK Ltd has acquired UK Biocentre Limited for GBP 20.5 million, net of cash and inclusive of up to GBP 1.8 million in contingent consideration upon completion of certain milestones.</p> <p>The acquisition expands Azenta's biorepository capabilities in the United Kingdom and establishes UK Biocentre as a European operational hub to support pharmaceutical, biotechnology, academic, and public health customers across the region. UK Biocentre will continue operating under its existing name and will support Azenta's established biorepository in Griesheim, Germany.</p> <p>Founded in 2014, UK Biocentre provides sample management, sample storage and high-throughput sample processing http://www.streetinsider.com/Mergers+and+Acquisitions/Azenta+acquires+UK+Biocentre+Limited+for+GBP+20.5+million/26108207.html Wed, 04 Mar 2026 09:11:17 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/Mergers+and+Acquisitions/Azenta+acquires+UK+Biocentre+Limited+for+GBP+20.5+million/26108207.html <p>Azenta, Inc. (NASDAQ: AZTA) announced that its subsidiary Azenta UK Ltd has acquired UK Biocentre Limited for GBP 20.5 million, net of cash and inclusive of up to GBP 1.8 million in contingent consideration upon completion of certain milestones.</p> <p>The acquisition expands Azenta's biorepository capabilities in the United Kingdom and establishes UK Biocentre as a European operational hub to support pharmaceutical, biotechnology, academic, and public health customers across the region. UK Biocentre will continue operating under its existing name and will support Azenta's established biorepository in Griesheim, Germany.</p> <p>Founded in 2014, UK Biocentre provides sample management, sample storage and high-throughput sample processing http://www.streetinsider.com/Mergers+and+Acquisitions/Azenta+acquires+UK+Biocentre+Limited+for+GBP+20.5+million/26108207.html Wed, 04 Mar 2026 09:11:17 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/Press+Releases/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>March 4, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, <span>Azenta UK Ltd</span>, has acquired <span value="ACORN:5021481101" idsrc="xmltag.org" >UK Biocentre Limited</span>, a leading provider of sample management, sample storage and high-throughput sample processing services in the <location value="LC/gb" idsrc="xmltag.org" >United Kingdom</location>. The total consideration was <money>GBP 20.5 million</money>, net of cash and inclusive of up to <money>GBP 1.8 million</money> in contingent consideration upon the completion of certain milestones.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html Wed, 04 Mar 2026 09:11:00 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/Press+Releases/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>March 4, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, <span>Azenta UK Ltd</span>, has acquired <span value="ACORN:5021481101" idsrc="xmltag.org" >UK Biocentre Limited</span>, a leading provider of sample management, sample storage and high-throughput sample processing services in the <location value="LC/gb" idsrc="xmltag.org" >United Kingdom</location>. The total consideration was <money>GBP 20.5 million</money>, net of cash and inclusive of up to <money>GBP 1.8 million</money> in contingent consideration upon the completion of certain milestones.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html Wed, 04 Mar 2026 09:11:00 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/Press+Releases/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>March 4, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, <span>Azenta UK Ltd</span>, has acquired <span value="ACORN:5021481101" idsrc="xmltag.org" >UK Biocentre Limited</span>, a leading provider of sample management, sample storage and high-throughput sample processing services in the <location value="LC/gb" idsrc="xmltag.org" >United Kingdom</location>. The total consideration was <money>GBP 20.5 million</money>, net of cash and inclusive of up to <money>GBP 1.8 million</money> in contingent consideration upon the completion of certain milestones.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html Wed, 04 Mar 2026 09:11:00 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/Press+Releases/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>March 4, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, <span>Azenta UK Ltd</span>, has acquired <span value="ACORN:5021481101" idsrc="xmltag.org" >UK Biocentre Limited</span>, a leading provider of sample management, sample storage and high-throughput sample processing services in the <location value="LC/gb" idsrc="xmltag.org" >United Kingdom</location>. The total consideration was <money>GBP 20.5 million</money>, net of cash and inclusive of up to <money>GBP 1.8 million</money> in contingent consideration upon the completion of certain milestones.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html Wed, 04 Mar 2026 09:11:00 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/Press+Releases/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>March 4, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, <span>Azenta UK Ltd</span>, has acquired <span value="ACORN:5021481101" idsrc="xmltag.org" >UK Biocentre Limited</span>, a leading provider of sample management, sample storage and high-throughput sample processing services in the <location value="LC/gb" idsrc="xmltag.org" >United Kingdom</location>. The total consideration was <money>GBP 20.5 million</money>, net of cash and inclusive of up to <money>GBP 1.8 million</money> in contingent consideration upon the completion of certain milestones.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html Wed, 04 Mar 2026 09:11:00 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/Press+Releases/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>March 4, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, <span>Azenta UK Ltd</span>, has acquired <span value="ACORN:5021481101" idsrc="xmltag.org" >UK Biocentre Limited</span>, a leading provider of sample management, sample storage and high-throughput sample processing services in the <location value="LC/gb" idsrc="xmltag.org" >United Kingdom</location>. The total consideration was <money>GBP 20.5 million</money>, net of cash and inclusive of up to <money>GBP 1.8 million</money> in contingent consideration upon the completion of certain milestones.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html Wed, 04 Mar 2026 09:11:00 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/Press+Releases/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>March 4, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, <span>Azenta UK Ltd</span>, has acquired <span value="ACORN:5021481101" idsrc="xmltag.org" >UK Biocentre Limited</span>, a leading provider of sample management, sample storage and high-throughput sample processing services in the <location value="LC/gb" idsrc="xmltag.org" >United Kingdom</location>. The total consideration was <money>GBP 20.5 million</money>, net of cash and inclusive of up to <money>GBP 1.8 million</money> in contingent consideration upon the completion of certain milestones.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html Wed, 04 Mar 2026 09:11:00 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/Press+Releases/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>March 4, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, <span>Azenta UK Ltd</span>, has acquired <span value="ACORN:5021481101" idsrc="xmltag.org" >UK Biocentre Limited</span>, a leading provider of sample management, sample storage and high-throughput sample processing services in the <location value="LC/gb" idsrc="xmltag.org" >United Kingdom</location>. The total consideration was <money>GBP 20.5 million</money>, net of cash and inclusive of up to <money>GBP 1.8 million</money> in contingent consideration upon the completion of certain milestones.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html Wed, 04 Mar 2026 09:11:00 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/Press+Releases/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>March 4, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, <span>Azenta UK Ltd</span>, has acquired <span value="ACORN:5021481101" idsrc="xmltag.org" >UK Biocentre Limited</span>, a leading provider of sample management, sample storage and high-throughput sample processing services in the <location value="LC/gb" idsrc="xmltag.org" >United Kingdom</location>. The total consideration was <money>GBP 20.5 million</money>, net of cash and inclusive of up to <money>GBP 1.8 million</money> in contingent consideration upon the completion of certain milestones.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html Wed, 04 Mar 2026 09:11:00 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/Press+Releases/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>March 4, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, <span>Azenta UK Ltd</span>, has acquired <span value="ACORN:5021481101" idsrc="xmltag.org" >UK Biocentre Limited</span>, a leading provider of sample management, sample storage and high-throughput sample processing services in the <location value="LC/gb" idsrc="xmltag.org" >United Kingdom</location>. The total consideration was <money>GBP 20.5 million</money>, net of cash and inclusive of up to <money>GBP 1.8 million</money> in contingent consideration upon the completion of certain milestones.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html Wed, 04 Mar 2026 09:11:00 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/PRNewswire/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>March 4, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, <span>Azenta UK Ltd</span>, has acquired <span value="ACORN:5021481101" idsrc="xmltag.org" >UK Biocentre Limited</span>, a leading provider of sample management, sample storage and high-throughput sample processing services in the <location value="LC/gb" idsrc="xmltag.org" >United Kingdom</location>. The total consideration was <money>GBP 20.5 million</money>, net of cash and inclusive of up to <money>GBP 1.8 million</money> in contingent consideration upon the completion of certain milestones.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html Wed, 04 Mar 2026 09:11:00 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/PRNewswire/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>March 4, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, <span>Azenta UK Ltd</span>, has acquired <span value="ACORN:5021481101" idsrc="xmltag.org" >UK Biocentre Limited</span>, a leading provider of sample management, sample storage and high-throughput sample processing services in the <location value="LC/gb" idsrc="xmltag.org" >United Kingdom</location>. The total consideration was <money>GBP 20.5 million</money>, net of cash and inclusive of up to <money>GBP 1.8 million</money> in contingent consideration upon the completion of certain milestones.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html Wed, 04 Mar 2026 09:11:00 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540 http://www.streetinsider.com/PRNewswire/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ma.burltn" idsrc="xmltag.org" >BURLINGTON, Mass.</location></span>, <span class="legendSpanClass"><chron>March 4, 2026</chron></span> /PRNewswire/ -- <span value="NASDAQ-NMS:AZTA" idsrc="xmltag.org" >Azenta, Inc.</span> (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, <span>Azenta UK Ltd</span>, has acquired <span value="ACORN:5021481101" idsrc="xmltag.org" >UK Biocentre Limited</span>, a leading provider of sample management, sample storage and high-throughput sample processing services in the <location value="LC/gb" idsrc="xmltag.org" >United Kingdom</location>. The total consideration was <money>GBP 20.5 million</money>, net of cash and inclusive of up to <money>GBP 1.8 million</money> in contingent consideration upon the completion of certain milestones.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Azenta+Completes+Strategic+Acquisition+of+UK+Biocentre+Limited%2C+to+Expand+Biorepository+Capabilities/26108205.html Wed, 04 Mar 2026 09:11:00 -0500 A.01306995 A.15377990 A.23374197 A.50214811 AZTA O.00030612 O.00162109 O.05964282 O.06189184 O.10867540